The Duke Cancer Institute (DCI) is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital.[1] Founded in 1971, the center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States.[2][3]
| Duke Cancer Institute | |
|---|---|
 | |
| Geography | |
| Location | Durham, North Carolina, United States |
| Coordinates | 36°00′14″N 78°56′20″W? / ?36.003767°N 78.938812°W |
| Organization | |
| Type | Specialist |
| Affiliated university | Duke University |
| Services | |
| Speciality | Oncology |
| History | |
| Opened | 1971 |
| Links | |
| Website | dukecancerinstitute |
| Lists | Hospitals in North Carolina |
The center specializes in the treatment and prevention of cancer and was ranked 41st in the U.S. News & World Report's 2021 list of top cancer hospitals.[4] More than 10,000 new cancer patients are seen at Duke each year.[5] The institute signed the National Cancer Act of 1971 and became an NCI-designated cancer center in 1973.[6]
In November 2010, Victor Dzau, MD, chancellor of health affairs for Duke University, formally unveiled the Duke Cancer Institute, during the topping out ceremony for the new building.[7]
The DCI is a single entity—the first of its kind at Duke—that integrates and aligns patient care and basic and clinical research with the goals of improving patient outcomes, decreasing the burden of cancer and accelerating scientific progress.[8]
Michael B. Kastan, a cancer scientist and Director of the Comprehensive Cancer Center at St. Jude Children’s Research Hospital, was named as the first Executive Director of the Duke Cancer Institute in May 2011.[9] Eun-Sil Shelley Hwang became the institute's first female Chief of Breast Surgery.[10]
On February 27, 2012, the Duke Cancer Institute opened the Duke Cancer Center, a new seven-floor building devoted exclusively to cancer care.[11]
Clinical milestones
editIn June 2018, the institute published a study in The New England Journal of Medicine showing how a genetically modified poliovirus therapy improved long-term survival for patients with recurrent glioblastoma.[12][13][14] Patients showed a three-year survival rate of 21 percent.[15]
References
edit- ^ "Duke Comprehensive Cancer Center". cancer.gov. National Cancer Institute. Archived from the original on August 20, 2007. Retrieved July 30, 2009.
- ^ "Cancer Services". Duke University Health System. Retrieved July 30, 2009.
- ^ Thomas, Patrick (April 14, 2022). "Cancer survivor highlight of Duke Cancer Institute 50th anniversary". spectrumlocalnews.com. Retrieved February 13, 2023.
- ^ "Best Cancer Hospitals". U.S. News & World Report. Retrieved May 25, 2021.
- ^ "About - Duke Cancer Institute". Duke Cancer Institute. Retrieved May 25, 2021.
- ^ "50 years of Duke cancer care". The Cancer Letter. July 8, 2022. Retrieved February 13, 2023.
- ^ "Public gets first official glimpse at Duke Cancer Center at topping-out ceremony". Herald Sun. Archived from the original on September 27, 2011. Retrieved November 24, 2010.
- ^ "Cancer Centers Program". National Cancer Institute. Archived from the original on August 20, 2007. Retrieved July 5, 2011.
- ^ "Kastan to Lead Duke Cancer Institute". Duke Chronicle. Retrieved July 5, 2011.
- ^ "First female chief of breast surgery at Duke named one of Time's 'Most Influential Americans'". apnews.com. March 26, 2018. Retrieved March 29, 2020.
- ^ "OPEN HOUSE FOR NEW DUKE CANCER CENTER". today.duke.edu. February 14, 2012. Retrieved March 29, 2020.
- ^ "Brain Cancer Gets the Polio Treatment". Genetic Engineering and Biotechnology News. June 26, 2018. Retrieved February 13, 2023.
- ^ Desjardins, Annick; Matthias, Gromeier; Herndon, James E. (July 12, 2018). "Recurrent Glioblastoma Treated with Recombinant Poliovirus". The New England Journal of Medicine.
- ^ Cohut, Maria (February 1, 2020). "How a modified poliovirus may help fight brain cancer". www.medicalnewstoday.com. Retrieved February 13, 2023.
- ^ "Poliovirus Extends Survival for Patients With Glioblastoma in Early-Phase Trial". Cure Today. Retrieved February 13, 2023.